| Pack Size/Qty | Price | Unit Price | |
| 90 Tablet/s | $414.00 | $4.60 | |
| 60 Tablet/s | $282.00 | $4.70 | |
| 30 Tablet/s | $144.00 | $4.80 |
Generic Name : Ganciclovir
Brand Name : Natclovir
Manufacturer Name : Natco Pharma India
Product Code : CRX 158
Delivery Days : 10 to 15 working days
Strength : 250 mg
Packaging : Capsules (Blister Packing)
Natclovir 250 mg is a potent antiviral medication used to treat a variety of viral infections, with its primary application in the management of cytomegalovirus (CMV) infections in immunocompromised individuals, such as those with HIV/AIDS or recipients of organ transplants. This medication is an essential component of modern healthcare, playing a critical role in preventing and treating serious viral infections. In this comprehensive overview, we will delve into the details of Natclovir 250 mg, including its composition, mechanism of action, indications, dosages, potential side effects, and more.
Natclovir 250 mg contains the active ingredient Ganciclovir, which is a synthetic nucleoside analog of guanosine. It is available in the form of tablets, capsules, and intravenous formulations, making it adaptable for various administration methods.
Ganciclovir, the key component of Natclovir, exerts its antiviral effects by interfering with the replication of DNA in susceptible viruses, primarily CMV. Ganciclovir is phosphorylated within infected cells, leading to the formation of triphosphate, which inhibits viral DNA synthesis by acting as a chain terminator. This mechanism effectively prevents the virus from multiplying and spreading throughout the body.
Cytomegalovirus (CMV) Retinitis: Natclovir is most commonly prescribed for the treatment of CMV retinitis in patients with HIV/AIDS. CMV retinitis is a potentially blinding eye infection that can affect individuals with compromised immune systems. Natclovir helps to control the progression of the disease, preserving vision and preventing its spread to the other eye.
CMV Prophylaxis in Transplant Patients: For individuals who have received organ transplants, Natclovir is used as a prophylactic measure to prevent CMV infections. Organ transplant recipients often take immunosuppressive medications to prevent rejection, which increases their susceptibility to CMV. Natclovir reduces the risk of CMV infection in these patients.
Prevention of CMV in HIV/AIDS Patients: In people with advanced HIV/AIDS, CMV infections can be life-threatening. Natclovir may be prescribed to prevent CMV infections in this population, helping to maintain overall health and immune function.
Other CMV Infections: Natclovir can also be used to treat CMV infections that affect other organs, such as the gastrointestinal tract, lungs, and central nervous system.
The dosage of Natclovir can vary depending on the specific condition being treated and the patient's individual factors, such as renal function. It is essential to follow the prescribed dosage instructions provided by a healthcare professional. Typical dosages may include:
CMV Retinitis: The recommended oral dosage for CMV retinitis in HIV/AIDS patients is 1000 mg (two 500 mg tablets or capsules) taken three times a day for 14 to 21 days, followed by maintenance therapy of 1000 mg once daily.
CMV Prophylaxis in Transplant Patients: The recommended oral dosage for CMV prophylaxis is 1000 mg (two 500 mg tablets or capsules) taken three times a day, starting within 72 hours after transplantation and continuing for 100 days post-transplant.
Prevention of CMV in HIV/AIDS Patients: The recommended dosage for CMV prevention in patients with advanced HIV/AIDS is 1000 mg (two 500 mg tablets or capsules) taken three times a day.
Other CMV Infections: Dosages for other CMV infections may vary and should be determined by a healthcare provider.
Natclovir may also be administered intravenously under the supervision of a healthcare professional, typically at a dose of 5 mg/kg every 12 hours for CMV retinitis and prophylaxis. It is important to undergo regular monitoring during treatment, as the dosage may need to be adjusted based on the patient's response and any potential side effects.
While Natclovir is effective in treating viral infections, it can also cause side effects. Common side effects may include:
Nausea
Vomiting
Diarrhea
Headache
Fever
Rash
Neutropenia (low white blood cell count)
It's important to report any severe or persistent side effects to a healthcare provider. Natclovir can also cause more serious side effects, such as bone marrow suppression, kidney problems, and liver dysfunction. Regular monitoring of blood counts and kidney function is typically required during treatment to detect and manage potential complications.
Natclovir should not be used in individuals with known hypersensitivity to Ganciclovir or any of the excipients in the formulation. It is also contraindicated in pregnant women, as it can cause harm to the developing fetus. Women of childbearing potential should use effective contraception during Natclovir treatment.
Pregnancy and Breastfeeding: Women who are pregnant or planning to become pregnant should not use Natclovir, as it can harm the fetus. It is also not recommended for breastfeeding mothers, as it can be excreted in breast milk.
Renal Impairment: Natclovir may require dosage adjustments in patients with impaired renal function. Close monitoring of kidney function is crucial.
Hematological Abnormalities: Patients with pre-existing hematological abnormalities or those who experience a decrease in blood cell counts while taking Natclovir should be closely monitored.
Concomitant Medications: Natclovir can interact with other medications, potentially affecting their efficacy or causing adverse effects. Inform your healthcare provider of all medications you are taking.
Natclovir 250 mg, containing the active ingredient Ganciclovir, is a vital tool in the treatment and prevention of cytomegalovirus (CMV) infections, particularly in individuals with compromised immune systems. Its antiviral properties work by inhibiting the replication of viral DNA, helping to control and manage CMV-related conditions.
While Natclovir is highly effective, it is not without its side effects and contraindications. Close monitoring by healthcare professionals and adherence to prescribed dosages are essential to ensure its safety and efficacy. This medication has been instrumental in improving the quality of life for many patients with CMV infections, preventing vision loss, and aiding in the recovery of organ transplant recipients. As with any medication, it should be used under the guidance of a healthcare provider who can make the best treatment decisions based on individual patient needs.
